TITLE

AASLD Updates Chronic Hepatitis B Recommendations

AUTHOR(S)
HUNTZINGER, AMBER
PUB. DATE
February 2009
SOURCE
American Family Physician;2/15/2009, Vol. 79 Issue 4, p338
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the updated chronic hepatitis B virus (HBV) infection recommendations from the American Association for the Study of Liver Diseases (AASLD), which include the preferred diagnostic, therapeutic, and preventive approaches to chronic HBV. It notes that chronic HBV infection is defined as a necroinflammatory liver disease caused by persistent infection with HBV. It cites that interferons are utilized for a predefined duration, whereas nucleoside analogue (NA) treatment is used until certain endpoints are reached.
ACCESSION #
36381595

 

Related Articles

  • Hepatitis B resistance in Iran. Zali, Mohammad Reza // Gastroenterology & Hepatology from Bed to Bench;Apr2010, Vol. 3 Issue 2, p50 

    Emerging new medications in the treatment of HBV produces hope and promises for curing of HBV. Over the past decade, the development of oral nucleoside/nucleotide analogs (NAs) with favorable potencies and tolerabilities has led to substantial advances in chronic hepatitis B (CHB) therapy. The...

  • Therapy for hepatitis B in children confers no long-term benefit.  // Nursing Standard;1/2/2008, Vol. 22 Issue 17, p18 

    The article reports on the results of study about the efficacy of interferon-alpha on the overall long-term outcome in children with hepatitis B infection. According to the researchers in Italy, only mild to moderate disease in 91.2% from 57 evaluated children were observed and no patient...

  • Antiviral Activity of Bay 41-4109 on Hepatitis B Virus in Humanized Alb-uPA/SCID Mice. Brezillon, Nicolas; Brunelle, Marie-Noëlle; Massinet, Hé lène; Giang, Eric; Lamant, Cé line; DaSilva, Lucie; Berissi, Sophie; Belghiti, Jacques; Hannoun, Laurent; Puerstinger, Gherard; Wimmer, Eva; Neyts, Johan; Hantz, Olivier; Soussan, Patrick; Morosan, Serban; Kremsdorf, Dina // PLoS ONE;2011, Vol. 6 Issue 12, p1 

    Current treatments for HBV chronic carriers using interferon alpha or nucleoside analogues are not effective in all patients and may induce the emergence of HBV resistant strains. Bay 41-4109, a member of the heteroaryldihydropyrimidine family, inhibits HBV replication by destabilizing capsid...

  • Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Wong, David K.H.; Cheung, Angela M.; O'Rourke, Keith; Naylor, C. David; Detsky, Allan S.; Heathcote, Jenny; Wong, D K; Cheung, A M; O'Rourke, K; Naylor, C D; Detsky, A S; Heathcote, J // Annals of Internal Medicine;8/15/93, Vol. 119 Issue 4, p312 

    Purpose: To determine whether alpha-interferon is effective in terminating viral replication and in eradicating the carrier state in patients with chronic hepatitis B virus (HBV) infection.Data Sources: Randomized controlled studies published in the English literature...

  • Genotype Mixtures of Hepatitis B Virus in Patients Treated with Interferon. Hannoun, Charles; Krogsgaard, Kim; Horal, Petr; Lindh, Magnus // Journal of Infectious Diseases;9/15/2002, Vol. 186 Issue 6, p752 

    Little is known about coinfection among several hepatitis B virus (HBV) genotypes, although previous reports of recombination and genotype shifts indicate that this should occur. In the present study, we designed a method to identify mixtures of genotype A and another genotype, regardless of...

  • Entecavir: A Viewpoint by Robert G. Gish. Gish, Robert G. // Drugs;2006, Vol. 66 Issue 12, p1623 

    Orlistat (Xenical) is a reversible inhibitor of gastric and pancreatic lipases. In conjunction with a hypocaloric diet and moderate exercise, orlistat is an effective drug for use in the management of obesity in adults with or without comorbidities. Recent data have shown that orlistat is also...

  • Entecavir: A Viewpoint by Ching-Lung Lai and Man-Fung Yuen. Ching-Lung Lai; Man-Fung Yuen // Drugs;2006, Vol. 66 Issue 12, p1623 

    Orlistat (Xenical) is a reversible inhibitor of gastric and pancreatic lipases. In conjunction with a hypocaloric diet and moderate exercise, orlistat is an effective drug for use in the management of obesity in adults with or without comorbidities. Recent data have shown that orlistat is also...

  • Telbivudine. Keam, Susan J. // Drugs;2007, Vol. 67 Issue 13, p1917 

    Telbivudine, the unmodified L-nantiomer of the naturally occurring nucleoside D-thymidine, is a potent synthetic nucleoside analogue. It acts as a hepatitis B virus (HBV) polymerase inlubitor and preferentially inhibits HBV second strand (DNA-dependent) compared with first strand (RNA-dependent)...

  • AIDE-MEMOIRE: for an effective approach to the immunization of health workers against hepatitis B.  // Immunization Newsletter;2009, Vol. 31 Issue 6, p6 

    The article offers information on the concepts and definitions of hepatitis B virus, a viral infection that can cause both acute and chronic disease and affects the liver.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics